Informed consent for inclusion into clinical trials: a serious subject to note in the developing world.

Morteza Izadi, Mozhgan Fazel, Taha Nasiri-Vanashi, Seyed Hasan Saadat, Saeed Taheri
{"title":"Informed consent for inclusion into clinical trials: a serious subject to note in the developing world.","authors":"Morteza Izadi,&nbsp;Mozhgan Fazel,&nbsp;Taha Nasiri-Vanashi,&nbsp;Seyed Hasan Saadat,&nbsp;Saeed Taheri","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Informed consent is a critical issue especially in conducting clinical trials that expose human life to medical or surgical interventions. It necessitates a long and complex process through which the participant is presented with all potential favorable and non-favorable consequences upon getting enrolled in the study.</p><p><strong>Review: </strong>The process of taking informed consent is well-understood in developed countries, with every effort taken to enhance and maintain the autonomy of patients and their right to make an informed choice of whether to participate or not. This may not be the case in the developing world.The information given to patients before the trial might not be properly developed and presented, an issue that can result in serious threat to the decision-making process. On the other hand, investigators should remember that enrolling people into a trial with no potential benefit for themselves cannot be considered ethical. In the current debate, we aim to address the issue of how respectfully and ethically clinical research trials can be done on human subjects and what we can do to enhance the practice in an ethical context.</p><p><strong>Conclusion: </strong>Development of a system through which we could warrant all rights of study participants in all cases around the world seems far from view. However, if we are in doubt about the ethics of a clinical trial, we can ask ourselves: \"what would we do, if we were in the same position our patients are in now?\"</p>","PeriodicalId":89079,"journal":{"name":"Arab journal of nephrology and transplantation","volume":"5 2","pages":"97-100"},"PeriodicalIF":0.0000,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arab journal of nephrology and transplantation","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Informed consent is a critical issue especially in conducting clinical trials that expose human life to medical or surgical interventions. It necessitates a long and complex process through which the participant is presented with all potential favorable and non-favorable consequences upon getting enrolled in the study.

Review: The process of taking informed consent is well-understood in developed countries, with every effort taken to enhance and maintain the autonomy of patients and their right to make an informed choice of whether to participate or not. This may not be the case in the developing world.The information given to patients before the trial might not be properly developed and presented, an issue that can result in serious threat to the decision-making process. On the other hand, investigators should remember that enrolling people into a trial with no potential benefit for themselves cannot be considered ethical. In the current debate, we aim to address the issue of how respectfully and ethically clinical research trials can be done on human subjects and what we can do to enhance the practice in an ethical context.

Conclusion: Development of a system through which we could warrant all rights of study participants in all cases around the world seems far from view. However, if we are in doubt about the ethics of a clinical trial, we can ask ourselves: "what would we do, if we were in the same position our patients are in now?"

纳入临床试验的知情同意:发展中国家需要注意的一个严肃问题。
引言:知情同意是一个关键问题,特别是在进行将人的生命暴露于医学或外科干预的临床试验时。这需要一个漫长而复杂的过程,通过这个过程,参与者在参加这项研究时,会被告知所有潜在的有利和不利的后果。回顾:在发达国家,获得知情同意的过程得到了充分的理解,并尽一切努力加强和维护患者的自主权,以及他们做出是否参与的知情选择的权利。发展中国家的情况可能并非如此。试验前提供给患者的信息可能没有得到适当的发展和呈现,这一问题可能对决策过程造成严重威胁。另一方面,研究人员应该记住,让人们参加一项对他们自己没有潜在好处的试验不能被认为是道德的。在当前的辩论中,我们的目标是解决如何尊重和道德地对人类受试者进行临床研究试验的问题,以及我们可以做些什么来加强在道德背景下的实践。结论:开发一个系统,通过它我们可以保证研究参与者在世界各地的所有情况下的所有权利似乎遥不可及。然而,如果我们对临床试验的伦理有疑问,我们可以问自己:“如果我们处于我们的病人现在所处的位置,我们会怎么做?”
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书